Current Diabetes Reports recently published research done by dQ&A Research Manager, Trevor Bell. Psychosocial Assessment Tools for Youth with Type 1 Diabetes: a 10-Year Review focuses on the critical role psychosocial issues play in diabetes management. There has been a significant push for healthcare providers, researchers, and policymakers to take these into account when working with patients. This is especially true for youth with Type 1 diabetes who have to deal with the demands of diabetes management while also facing challenges that emerge while growing up.
“One of the best ways that we can understand what youths are facing is to assess these factors through research. However, psychosocial issues are so broad and there are so many ways we can assess them. So we looked at 10 years’ worth of published articles evaluating psychosocial issues affecting youth to identify the most common, and hopefully most effective, ways to assess these issues, while also uncovering how the field is evolving.” explains Trevor about the research he and Elizabeth Hazel conducted.
Read the full piece here and please join us in congratulating Trevor on this incredible work!
This article was first published online in Current Diabetes Reports by Springer Nature on Nov. 24, 2022.
About dQ&A – The Diabetes Research Company
dQ&A is a social enterprise committed to making life better for people with diabetes. We harness patient voices to drive better business results and better health outcomes. For over 14 years, we have been comprehensively tracking the diabetes experience in the United States, Canada, and Europe. We are trusted by diabetes industry leaders for our independence, commitment, and expertise. Our team has decades of experience in quantitative and qualitative research with a deep knowledge of diabetes. We’re efficient and effective; our insights are actionable and accessible. To learn more, send us an email at firstname.lastname@example.org. For research highlights, visit us at d-qa.com and follow us on LinkedIn (dQ&A – The Diabetes Research Company)